{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:22:30Z","timestamp":1793247750752,"version":"4.5.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11064-022-03667-0","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T02:03:39Z","timestamp":1657245819000},"page":"2954-2962","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Icariin: A Potential Neuroprotective Agent in Alzheimer\u2019s Disease and Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"47","author":[{"given":"Mohammad Rafi","family":"Khezri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5672-9202","authenticated-orcid":false,"given":"Morteza","family":"Ghasemnejad-Berenji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"key":"3667_CR1","volume-title":"Handbook of Chinese medicinal plants","author":"W Tang","year":"2011","unstructured":"Tang W, Eisenbrand G (2011) Handbook of Chinese medicinal plants. John Wiley, Hoboken"},{"issue":"10","key":"3667_CR2","first-page":"604","volume":"15","author":"C Ding","year":"1990","unstructured":"Ding C (1990) Determination of icarim in luohan jindan oral liquid by thin-layer chromatography. J Chin Materia Med 15(10):604\u2013606","journal-title":"J Chin Materia Med"},{"key":"3667_CR3","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3389\/fphar.2020.00951","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen Z et al (2020) Detrimental effect of sitagliptin induced autophagy on multiterritory perforator flap survival. Front Pharmacol 11:951","journal-title":"Front Pharmacol"},{"issue":"3","key":"3667_CR4","doi-asserted-by":"publisher","first-page":"155932582095956","DOI":"10.1177\/1559325820959563","volume":"18","author":"N Munir","year":"2020","unstructured":"Munir N et al (2020) Therapeutic response of Epimedium gandiflorum\u2019s different doses to restore the antioxidant potential and reproductive hormones in male albino rats. Dose Response 18(3):1559325820959563","journal-title":"Dose Response"},{"issue":"9","key":"3667_CR5","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1007\/s11095-008-9602-7","volume":"25","author":"Y Chen","year":"2008","unstructured":"Chen Y et al (2008) Intestinal absorption mechanisms of prenylated flavonoids present in the heat-processed Epimedium koreanum Nakai (Yin Yanghuo). Pharm Res 25(9):2190\u20132199","journal-title":"Pharm Res"},{"key":"3667_CR6","first-page":"4239","volume":"7","author":"Y Zhang","year":"2012","unstructured":"Zhang Y et al (2012) Changes in the intestinal absorption mechanism of icariin in the nanocavities of cyclodextrins. Int J Nanomed 7:4239","journal-title":"Int J Nanomed"},{"issue":"15\u201316","key":"3667_CR7","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jchromb.2010.03.023","volume":"878","author":"H Zhao","year":"2010","unstructured":"Zhao H et al (2010) Liquid chromatography\u2013tandem mass spectrometry analysis of metabolites in rats after administration of prenylflavonoids from Epimediums. J Chromatogr B 878(15\u201316):1113\u20131124","journal-title":"J Chromatogr B"},{"issue":"2","key":"3667_CR8","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3390\/molecules16021336","volume":"16","author":"Y Chen","year":"2011","unstructured":"Chen Y et al (2011) Role of intestinal hydrolase in the absorption of prenylated flavonoids present in Yinyanghuo. Molecules 16(2):1336\u20131348","journal-title":"Molecules"},{"key":"3667_CR9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jpba.2012.03.053","volume":"66","author":"Q Qian","year":"2012","unstructured":"Qian Q et al (2012) Metabolite profiles of icariin in rat plasma by ultra-fast liquid chromatography coupled to triple-quadrupole\/time-of-flight mass spectrometry. J Pharm Biomed Anal 66:392\u2013398","journal-title":"J Pharm Biomed Anal"},{"key":"3667_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fnmol.2018.00155","volume":"11","author":"D-S Lu","year":"2018","unstructured":"Lu D-S et al (2018) Combination treatment of Icariin and L-DOPA against 6-OHDA-Lesioned dopamine neurotoxicity. Front Mol Neurosci 11:155","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"3667_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.2042-7158.2011.01388.x","volume":"64","author":"W Yang","year":"2012","unstructured":"Yang W et al (2012) Pharmacokinetics and tissue distribution profile of icariin propylene glycol-liposome intraperitoneal injection in mice. J Pharm Pharmacol 64(2):190\u2013198","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"3667_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00381-020-04690-8","volume":"37","author":"M Wang","year":"2021","unstructured":"Wang M, Rong Y, Luo L (2021) Neuroprotective effects of icariin in neonatal hypoxia-ischemic brain damage via its anti-apoptotic property. Child\u2019s Nerv Syst 37(1):39\u201346","journal-title":"Child\u2019s Nerv Syst"},{"key":"3667_CR13","doi-asserted-by":"publisher","first-page":"4684962","DOI":"10.1155\/2017\/4684962","volume":"2017","author":"S Xu","year":"2017","unstructured":"Xu S et al (2017) Pharmacokinetics, tissue distribution, and metabolism study of icariin in rat. BioMed Res Int 2017:4684962","journal-title":"BioMed Res Int"},{"issue":"4","key":"3667_CR14","doi-asserted-by":"publisher","first-page":"a033118","DOI":"10.1101\/cshperspect.a033118","volume":"10","author":"MG Erkkinen","year":"2018","unstructured":"Erkkinen MG, Kim M-O, Geschwind MD (2018) Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb Perspect Biol 10(4):a033118","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3667_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-022-01191-x","author":"MR Khezri","year":"2022","unstructured":"Khezri MR et al (2022) The role of ERK1\/2 pathway in the pathophysiology of alzheimer\u2019s disease: an overview and update on new developments. Cell Mol Neurobiol. https:\/\/doi.org\/10.1007\/s10571-022-01191-x","journal-title":"Cell Mol Neurobiol"},{"key":"3667_CR16","doi-asserted-by":"publisher","first-page":"114945","DOI":"10.1016\/j.bcp.2022.114945","volume":"197","author":"MR Khezri","year":"2022","unstructured":"Khezri MR et al (2022) Metformin in alzheimer\u2019s disease: an overview of potential mechanisms, preclinical and clinical findings. Biochem Pharmacol 197:114945","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"3667_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.neuron.2019.01.058","volume":"101","author":"C Haass","year":"2019","unstructured":"Haass C, Willem M (2019) Secreted APP modulates synaptic activity: a novel target for therapeutic intervention? Neuron 101(4):557\u2013559","journal-title":"Neuron"},{"issue":"1","key":"3667_CR18","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1371\/journal.pmed.0020018","volume":"2","author":"S Pedrini","year":"2005","unstructured":"Pedrini S et al (2005) Modulation of statin-activated shedding of alzheimer APP ectodomain by ROCK. PLoS Med 2(1):e18","journal-title":"PLoS Med"},{"issue":"6","key":"3667_CR19","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1017\/S1461145713001533","volume":"17","author":"F Jin","year":"2014","unstructured":"Jin F et al (2014) Icariin, a phoshphodiesterase-5 inhibitor, improves learning and memory in APP\/PS1 transgenic mice by stimulation of NO\/cGMP signalling. Int J Neuropsychopharmacol 17(6):871\u2013881","journal-title":"Int J Neuropsychopharmacol"},{"key":"3667_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/cns.12473","volume":"22","author":"YJ Chen","year":"2016","unstructured":"Chen YJ et al (2016) Neuroprotective effects of icariin on brain metabolism, mitochondrial functions, and cognition in triple-transgenic Alzheimer\u2019s disease mice. CNS Neurosci Therap 22:63\u201373","journal-title":"CNS Neurosci Therap"},{"issue":"2","key":"3667_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7150\/ijbs.6232","volume":"10","author":"L Zhang","year":"2014","unstructured":"Zhang L et al (2014) Icariin decreases the expression of APP and BACE-1 and reduces the \u03b2-amyloid burden in an APP transgenic mouse model of Alzheimer\u2019s disease. Int J Biol Sci 10(2):181","journal-title":"Int J Biol Sci"},{"issue":"2\u20133","key":"3667_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ejphar.2009.09.039","volume":"626","author":"J Nie","year":"2010","unstructured":"Nie J et al (2010) Icariin inhibits beta-amyloid peptide segment 25\u201335 induced expression of \u03b2-secretase in rat hippocampus. Eur J Pharmacol 626(2\u20133):213\u2013218","journal-title":"Eur J Pharmacol"},{"key":"3667_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pbb.2015.09.001","volume":"138","author":"W-X Li","year":"2015","unstructured":"Li W-X et al (2015) Icariin, a major constituent of flavonoids from Epimedium brevicornum, protects against cognitive deficits induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in rats. Pharmacol Biochem Behav 138:40\u201348","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"3667_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","volume":"16","author":"SM Greenberg","year":"2020","unstructured":"Greenberg SM et al (2020) Cerebral amyloid angiopathy and alzheimer disease\u2014one peptide, two pathways. Nat Reviews Neurol 16(1):30\u201342","journal-title":"Nat Reviews Neurol"},{"issue":"12","key":"3667_CR25","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1007\/s00018-017-2463-7","volume":"74","author":"L Zuroff","year":"2017","unstructured":"Zuroff L et al (2017) Clearance of cerebral A\u03b2 in alzheimer\u2019s disease: reassessing the role of microglia and monocytes. Cell Mol Life Sci 74(12):2167\u20132201","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"3667_CR26","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.4161\/auto.29647","volume":"10","author":"M-H Cho","year":"2014","unstructured":"Cho M-H et al (2014) Autophagy in microglia degrades extracellular \u03b2-amyloid fibrils and regulates the NLRP3 inflammasome. Autophagy 10(10):1761\u20131775","journal-title":"Autophagy"},{"key":"3667_CR27","doi-asserted-by":"crossref","first-page":"7158444","DOI":"10.1155\/2021\/7158444","volume":"2021","author":"N Wang","year":"2021","unstructured":"Wang N et al (2021) The combination of \u03b2-asarone and icariin inhibits amyloid-\u03b2 and reverses cognitive deficits by promoting mitophagy in models of alzheimer\u2019s disease. Oxidative Med Cell Long 2021:7158444","journal-title":"Oxidative Med Cell Long"},{"issue":"12","key":"3667_CR28","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1007\/s11064-019-02889-z","volume":"44","author":"X Jiang","year":"2019","unstructured":"Jiang X et al (2019) Icariin ameliorates amyloid pathologies by maintaining homeostasis of autophagic systems in A\u03b21\u201342-injected rats. Neurochem Res 44(12):2708\u20132722","journal-title":"Neurochem Res"},{"issue":"1","key":"3667_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/13880209.2021.1878238","volume":"59","author":"J Zheng","year":"2021","unstructured":"Zheng J et al (2021) Icariin improves brain function decline in aging rats by enhancing neuronal autophagy through the AMPK\/mTOR\/ULK1 pathway. Pharm Biol 59(1):183\u2013191","journal-title":"Pharm Biol"},{"issue":"11","key":"3667_CR30","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.neurobiolaging.2009.12.010","volume":"32","author":"L Zhao","year":"2011","unstructured":"Zhao L et al (2011) 17\u03b2-Estradiol regulates insulin-degrading enzyme expression via an ER\u03b2\/PI3-K pathway in hippocampus: relevance to alzheimer\u2019s prevention. Neurobiol Aging 32(11):1949\u20131963","journal-title":"Neurobiol Aging"},{"key":"3667_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuroscience.2017.08.030","volume":"362","author":"N Yamamoto","year":"2017","unstructured":"Yamamoto N et al (2017) Epigallocatechin gallate induces extracellular degradation of amyloid \u03b2-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3K pathways. Neuroscience 362:70\u201378","journal-title":"Neuroscience"},{"key":"3667_CR32","doi-asserted-by":"publisher","first-page":"7464872","DOI":"10.1155\/2017\/7464872","volume":"2017","author":"C Sheng","year":"2017","unstructured":"Sheng C et al (2017) Icariin attenuates synaptic and cognitive deficits in an A\u03b21\u201342-induced rat model of alzheimer\u2019s disease. BioMed Res Int 2017:7464872","journal-title":"BioMed Res Int"},{"issue":"6","key":"3667_CR33","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.neuropharm.2010.07.020","volume":"59","author":"K-W Zeng","year":"2010","unstructured":"Zeng K-W et al (2010) Icariin attenuates \u03b2-amyloid-induced neurotoxicity by inhibition of tau protein hyperphosphorylation in PC12 cells. Neuropharmacology 59(6):542\u2013550","journal-title":"Neuropharmacology"},{"issue":"17","key":"3667_CR34","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1097\/WNR.0b013e328332d345","volume":"20","author":"D Sha","year":"2009","unstructured":"Sha D et al (2009) Icariin inhibits neurotoxicity of \u03b2-amyloid by upregulating cocaine-regulated and amphetamine-regulated transcripts. NeuroReport 20(17):1564\u20131567","journal-title":"NeuroReport"},{"key":"3667_CR35","first-page":"235265","volume":"2015","author":"D Zhang","year":"2015","unstructured":"Zhang D et al (2015) Icariin prevents amyloid beta-induced apoptosis via the PI3K\/Akt pathway in PC-12 cells. Evidence-Based Complement Alt Med 2015","journal-title":"Evidence-Based Complement Alt Med"},{"issue":"2","key":"3667_CR36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4103\/0971-5916.164254","volume":"142","author":"J Liu","year":"2015","unstructured":"Liu J et al (2015) A novel antagonistic role of natural compound icariin on neurotoxicity of amyloid \u03b2 peptide. Indian J Med Res 142(2):190","journal-title":"Indian J Med Res"},{"issue":"11","key":"3667_CR37","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3390\/molecules21111557","volume":"21","author":"X-A Li","year":"2016","unstructured":"Li X-A et al (2016) The protective effects of icariin against the homocysteine-induced neurotoxicity in the primary embryonic cultures of rat cortical neurons. Molecules 21(11):1557","journal-title":"Molecules"},{"issue":"9","key":"3667_CR38","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore C, Lee VM-Y, Trojanowski JQ (2007) Tau-mediated neurodegeneration in alzheimer\u2019s disease and related disorders. Nat Rev Neurosci 8(9):663\u2013672","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"3667_CR39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/JAD-2012-120805","volume":"33","author":"T Del Ser","year":"2013","unstructured":"Del Ser T et al (2013) Treatment of alzheimer\u2019s disease with the GSK-3 inhibitor tideglusib: a pilot study. J Alzheimers Dis 33(1):205\u2013215","journal-title":"J Alzheimers Dis"},{"key":"3667_CR40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/bab.2114","volume":"69","author":"Y Li","year":"2021","unstructured":"Li Y et al (2021) Icaritin and icariin reduce p-Tau levels in a cell model of alzheimer\u2019s disease by downregulating glycogen synthase kinase 3\u03b2. Biotechnol Appl Biochem 69:355","journal-title":"Biotechnol Appl Biochem"},{"issue":"2","key":"3667_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/ijms17020163","volume":"17","author":"Y Chen","year":"2016","unstructured":"Chen Y et al (2016) The protective effect of icariin on mitochondrial transport and distribution in primary hippocampal neurons from 3\u00d7 Tg-AD mice. Int J Mol Sci 17(2):163","journal-title":"Int J Mol Sci"},{"key":"3667_CR42","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s12035-022-02727-4","volume":"59","author":"MR Khezri","year":"2022","unstructured":"Khezri MR et al (2022) MicroRNAs in the pathophysiology of alzheimer\u2019s disease and parkinson\u2019s disease: an overview. Mol Neurobiol 59:1589","journal-title":"Mol Neurobiol"},{"key":"3667_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.brainres.2010.12.053","volume":"1375","author":"B Liu","year":"2011","unstructured":"Liu B et al (2011) Neuroprotective effects of icariin on corticosterone-induced apoptosis in primary cultured rat hippocampal neurons. Brain Res 1375:59\u201367","journal-title":"Brain Res"},{"issue":"2","key":"3667_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gendis.2019.01.004","volume":"6","author":"S Selvaraj","year":"2019","unstructured":"Selvaraj S, Piramanayagam S (2019) Impact of gene mutation in the development of parkinson\u2019s disease. Genes Dis 6(2):120\u2013128","journal-title":"Genes Dis"},{"issue":"2","key":"3667_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1172\/JCI200317575","volume":"111","author":"TM Dawson","year":"2003","unstructured":"Dawson TM, Dawson VL (2003) Rare genetic mutations shed light on the pathogenesis of parkinson disease. J Clin Investig 111(2):145\u2013151","journal-title":"J Clin Investig"},{"issue":"5b","key":"3667_CR46","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1111\/j.1582-4934.2008.00450.x","volume":"12","author":"C Roodveldt","year":"2008","unstructured":"Roodveldt C, Christodoulou J, Dobson CM (2008) Immunological features of \u03b1-synuclein in parkinson\u2019s disease. J Cell Mol Med 12(5b):1820\u20131829","journal-title":"J Cell Mol Med"},{"issue":"4","key":"3667_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11357-015-9811-z","volume":"37","author":"L Zhang","year":"2015","unstructured":"Zhang L et al (2015) Icariin reduces \u03b1-synuclein over-expression by promoting \u03b1-synuclein degradation. Age 37(4):1\u20139","journal-title":"Age"},{"issue":"45","key":"3667_CR48","doi-asserted-by":"publisher","first-page":"15123","DOI":"10.1523\/JNEUROSCI.4751-13.2014","volume":"34","author":"MS Choi","year":"2014","unstructured":"Choi MS et al (2014) Transnitrosylation from DJ-1 to PTEN attenuates neuronal cell death in parkinson\u2019s disease models. J Neurosci 34(45):15123\u201315131","journal-title":"J Neurosci"},{"issue":"3","key":"3667_CR49","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bcp.2014.11.012","volume":"93","author":"J Cao","year":"2015","unstructured":"Cao J et al (2015) DJ-1 as a human oncogene and potential therapeutic target. Biochem Pharmacol 93(3):241\u2013250","journal-title":"Biochem Pharmacol"},{"issue":"18","key":"3667_CR50","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1089\/neu.2018.6294","volume":"36","author":"CL Walker","year":"2019","unstructured":"Walker CL et al (2019) Bisperoxovanadium mediates neuronal protection through inhibition of PTEN and activation of PI3K\/AKT-mTOR signaling after traumatic spinal injuries. J Neurotrauma 36(18):2676\u20132687","journal-title":"J Neurotrauma"},{"issue":"2","key":"3667_CR51","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.neulet.2007.12.034","volume":"432","author":"K Nakaso","year":"2008","unstructured":"Nakaso K, Ito S, Nakashima K (2008) Caffeine activates the PI3K\/Akt pathway and prevents apoptotic cell death in a parkinson\u2019s disease model of SH-SY5Y cells. Neurosci Lett 432(2):146\u2013150","journal-title":"Neurosci Lett"},{"key":"3667_CR52","first-page":"93","volume":"15","author":"SUN X-C,","year":"2013","unstructured":"SUN X-C, et al (2013) PI3K\/Akt signaling pathway is involved in the neuroprotective effects of icariin on dopaminergic neurons in the mice model of parkinson\u2019s disease. Phytomedicine 15:93","journal-title":"Phytomedicine"},{"key":"3667_CR53","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3389\/fphar.2020.00880","volume":"11","author":"X Zou","year":"2020","unstructured":"Zou X et al (2020) Icariin attenuates amyloid-\u03b2 (A\u03b2)-Induced neuronal insulin resistance through PTEN downregulation. Front Pharmacol 11:880","journal-title":"Front Pharmacol"},{"issue":"1","key":"3667_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-017-1788-5","volume":"135","author":"P Jiang","year":"2018","unstructured":"Jiang P, Dickson DW (2018) Parkinson\u2019s disease: experimental models and reality. Acta Neuropathol 135(1):13\u201332","journal-title":"Acta Neuropathol"},{"issue":"2","key":"3667_CR55","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.foodchem.2013.04.004","volume":"141","author":"P Dewapriya","year":"2013","unstructured":"Dewapriya P et al (2013) Tyrosol exerts a protective effect against dopaminergic neuronal cell death in in vitro model of parkinson\u2019s disease. Food Chem 141(2):1147\u20131157","journal-title":"Food Chem"},{"issue":"1","key":"3667_CR56","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.fct.2010.10.029","volume":"49","author":"D-H Lee","year":"2011","unstructured":"Lee D-H, Kim C-S, Lee YJ (2011) Astaxanthin protects against MPTP\/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro. Food Chem Toxicol 49(1):271\u2013280","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"3667_CR57","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0006-8993(02)02551-9","volume":"943","author":"I Antol\u00edn","year":"2002","unstructured":"Antol\u00edn I et al (2002) Protective effect of melatonin in a chronic experimental model of parkinson\u2019s disease. Brain Res 943(2):163\u2013173","journal-title":"Brain Res"},{"key":"3667_CR58","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.phymed.2016.12.017","volume":"25","author":"W-F Chen","year":"2017","unstructured":"Chen W-F et al (2017) Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson\u2019s disease: Involvement of PI3K\/Akt and MEK\/ERK signaling pathways. Phytomedicine 25:93\u201399","journal-title":"Phytomedicine"},{"issue":"1","key":"3667_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1472-x","volume":"16","author":"B Zhang","year":"2019","unstructured":"Zhang B et al (2019) Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2-dependent manner. J Neuroinflamm 16(1):1\u201311","journal-title":"J Neuroinflamm"},{"key":"3667_CR60","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fnmol.2017.00441","volume":"10","author":"G-Q Wang","year":"2018","unstructured":"Wang G-Q et al (2018) Icariin reduces dopaminergic neuronal loss and microglia-mediated inflammation in vivo and in vitro. Front Mol Neurosci 10:441","journal-title":"Front Mol Neurosci"},{"key":"3667_CR61","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.toxrep.2019.06.014","volume":"6","author":"R Zeng","year":"2019","unstructured":"Zeng R et al (2019) Icariin-mediated activation of autophagy confers protective effect on rotenone induced neurotoxicity in vivo and in vitro. Toxicol Rep 6:637\u2013644","journal-title":"Toxicol Rep"},{"issue":"10","key":"3667_CR62","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","volume":"21","author":"S Hickman","year":"2018","unstructured":"Hickman S et al (2018) Microglia in neurodegeneration. Nat Neurosci 21(10):1359\u20131369","journal-title":"Nat Neurosci"},{"key":"3667_CR63","doi-asserted-by":"publisher","first-page":"109879","DOI":"10.1016\/j.cellsig.2020.109879","volume":"78","author":"ML Allende","year":"2021","unstructured":"Allende ML et al (2021) Genetic defects in the sphingolipid degradation pathway and their effects on microglia in neurodegenerative disease. Cell Signal 78:109879","journal-title":"Cell Signal"},{"issue":"1","key":"3667_CR64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","volume":"39","author":"MT Islam","year":"2017","unstructured":"Islam MT (2017) Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol Res 39(1):73\u201382","journal-title":"Neurol Res"},{"issue":"10","key":"3667_CR65","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41590-018-0212-1","volume":"19","author":"WM Song","year":"2018","unstructured":"Song WM, Colonna M (2018) The identity and function of microglia in neurodegeneration. Nat Immunol 19(10):1048\u20131058","journal-title":"Nat Immunol"},{"key":"3667_CR66","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fnins.2019.00291","volume":"13","author":"Y Wang","year":"2019","unstructured":"Wang Y et al (2019) Icariin attenuates M1 activation of microglia and A\u03b2 plaque accumulation in the hippocampus and prefrontal cortex by up-regulating PPAR\u03b3 in restraint\/isolation-stressed APP\/PS1 mice. Front NeuroSci 13:291","journal-title":"Front NeuroSci"},{"issue":"10","key":"3667_CR67","first-page":"136","volume":"3","author":"W-Y Wang","year":"2015","unstructured":"Wang W-Y et al (2015) Role of pro-inflammatory cytokines released from microglia in alzheimer\u2019s disease. Annal Trans Med 3(10):136","journal-title":"Annal Trans Med"},{"issue":"5","key":"3667_CR68","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2174\/1381612822666151125000300","volume":"22","author":"Q Alam","year":"2016","unstructured":"Alam Q et al (2016) Inflammatory process in alzheimer\u2019s and parkinson\u2019s diseases: central role of cytokines. Curr Pharm Design 22(5):541\u2013548","journal-title":"Curr Pharm Design"},{"issue":"4","key":"3667_CR69","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1046\/j.1365-2990.1998.00116.x","volume":"24","author":"I Ferrer","year":"1998","unstructured":"Ferrer I et al (1998) NF-kB immunoreactivity is observed in association with beta A4 diffuse plaques in patients with alzheimer\u2019s disease. Neuropathol Appl Neurobiol 24(4):271\u2013277","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3667_CR70","doi-asserted-by":"publisher","first-page":"755246","DOI":"10.3389\/fimmu","volume":"12","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S et al (2021) Expression analysis of NF-kB-related lncRNAs in parkinson\u2019s disease. Front Immunol 12:755246. https:\/\/doi.org\/10.3389\/fimmu","journal-title":"Front Immunol"},{"key":"3667_CR71","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/1568007033482959","volume":"2","author":"V Matteo","year":"2003","unstructured":"Matteo V, Esposito E (2003) Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer\u2019s disease, parkinson\u2019s disease, and amyotrophic lateral sclerosis. \u00a0Curr Drug Targets-CNS\u00a0 Neurol Disorder 2:95\u2013107","journal-title":"\u00a0Curr Drug Targets-CNS\u00a0 Neurol Disorder"},{"issue":"3","key":"3667_CR72","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12640-019-00147-2","volume":"37","author":"SS Singh","year":"2020","unstructured":"Singh SS et al (2020) NF-\u03baB-mediated neuroinflammation in parkinson\u2019s disease and potential therapeutic effect of polyphenols. Neurotox Res 37(3):491\u2013507","journal-title":"Neurotox Res"},{"key":"3667_CR73","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neulet.2013.04.056","volume":"547","author":"E Pranski","year":"2013","unstructured":"Pranski E et al (2013) NF-\u03baB activity is inversely correlated to RNF11 expression in parkinson\u2019s disease. Neurosci Lett 547:16\u201320","journal-title":"Neurosci Lett"},{"issue":"6","key":"3667_CR74","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.intimp.2010.03.010","volume":"10","author":"K-W Zeng","year":"2010","unstructured":"Zeng K-W et al (2010) Icariin attenuates lipopolysaccharide-induced microglial activation and resultant death of neurons by inhibiting TAK1\/IKK\/NF-\u03baB and JNK\/p38 MAPK pathways. Int Immunopharmacol 10(6):668\u2013678","journal-title":"Int Immunopharmacol"},{"key":"3667_CR75","doi-asserted-by":"publisher","first-page":"272","DOI":"10.2741\/4206","volume":"19","author":"H Lee","year":"2014","unstructured":"Lee H, Pienaar IS (2014) Disruption of the blood-brain barrier in parkinson\u2019s disease: curse or route to a cure. Front Biosci (Landmark Ed) 19:272\u2013280","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"10","key":"3667_CR76","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","volume":"33","author":"MA Erickson","year":"2013","unstructured":"Erickson MA, Banks WA (2013) Blood\u2013brain barrier dysfunction as a cause and consequence of alzheimer\u2019s disease. J Cereb Blood Flow Metabolism 33(10):1500\u20131513","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"3667_CR77","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/1061186X.2021.2023159","volume":"30","author":"W Yang","year":"2021","unstructured":"Yang W et al (2021) Intradermal injection of icariin-HP-\u03b2-cyclodextrin improved traumatic brain injury via the trigeminal epineurium-brain dura pathway. J Drug Target 30:557","journal-title":"J Drug Target"},{"issue":"2","key":"3667_CR78","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.intimp.2014.12.015","volume":"24","author":"R Shen","year":"2015","unstructured":"Shen R et al (2015) A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis. Int Immunopharmacol 24(2):224\u2013231","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"3667_CR79","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/brain\/awaa021","volume":"143","author":"EN Wilson","year":"2020","unstructured":"Wilson EN et al (2020) Soluble TREM2 is elevated in parkinson\u2019s disease subgroups with increased CSF tau. Brain 143(3):932\u2013943","journal-title":"Brain"},{"issue":"1","key":"3667_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-016-0182-1","volume":"8","author":"K Henjum","year":"2016","unstructured":"Henjum K et al (2016) Cerebrospinal fluid soluble TREM2 in aging and alzheimer\u2019s disease. Alzheimers Res Ther 8(1):1\u201311","journal-title":"Alzheimers Res Ther"},{"key":"3667_CR81","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neulet.2017.09.034","volume":"660","author":"D Feuerbach","year":"2017","unstructured":"Feuerbach D et al (2017) ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157. Neurosci Lett 660:109\u2013114","journal-title":"Neurosci Lett"},{"issue":"10","key":"3667_CR82","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.15252\/emmm.201707672","volume":"9","author":"K Schlepckow","year":"2017","unstructured":"Schlepckow K et al (2017) An alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function. EMBO Mol Med 9(10):1356\u20131365","journal-title":"EMBO Mol Med"},{"issue":"1","key":"3667_CR83","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev.pa.36.040196.000503","volume":"36","author":"N Simonian","year":"1996","unstructured":"Simonian N, Coyle J (1996) Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 36(1):83\u2013106","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3667_CR84","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1742-7843.2010.00595.x","volume":"107","author":"L Zhang","year":"2010","unstructured":"Zhang L et al (2010) Icariin inhibits hydrogen peroxide-mediated cytotoxicity by up-regulating sirtuin type 1-dependent catalase and peroxiredoxin. Basic Clin Pharmacol Toxicol 107:899\u2013905","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"8","key":"3667_CR85","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/j.1440-1681.2007.04647.x","volume":"34","author":"Y Luo","year":"2007","unstructured":"Luo Y et al (2007) Protective effects of icariin against learning and memory deficits induced by aluminium in rats. Clin Exp Pharmacol Physiol 34(8):792\u2013795","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"4","key":"3667_CR86","doi-asserted-by":"publisher","first-page":"731","DOI":"10.4103\/1673-5374.230302","volume":"13","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Kong W-N, Chai X-Q (2018) Compound of icariin, astragalus, and puerarin mitigates iron overload in the cerebral cortex of alzheimer\u2019s disease mice. Neural Regener Res 13(4):731","journal-title":"Neural Regener Res"},{"key":"3667_CR87","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma Q (2013) Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 53:401\u2013426","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3667_CR88","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.intimp.2019.05.033","volume":"73","author":"Y Zheng","year":"2019","unstructured":"Zheng Y et al (2019) Icariin targets Nrf2 signaling to inhibit microglia-mediated neuroinflammation. Int Immunopharmacol 73:304\u2013311","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"3667_CR89","first-page":"465","volume":"66","author":"L Zhu","year":"2019","unstructured":"Zhu L et al (2019) Activation of Nrf2 signaling by Icariin protects against 6-OHDA\u2010induced neurotoxicity. Biotechnol Appl Chem 66(3):465\u2013471","journal-title":"Biotechnol Appl Chem"},{"issue":"1","key":"3667_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5115\/acb.2016.49.1.1","volume":"49","author":"G Sweeney","year":"2016","unstructured":"Sweeney G, Song J (2016) The association between PGC-1\u03b1 and alzheimer\u2019s disease. Anat cell biology 49(1):1\u20136","journal-title":"Anat cell biology"},{"issue":"52","key":"3667_CR91","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1126\/scitranslmed.3001059","volume":"2","author":"B Zheng","year":"2010","unstructured":"Zheng B et al (2010) Pgc-1 \u03b1, a potential therapeutic target for early intervention in parkinson\u2019s disease. Sci Trans Med 2(52):73","journal-title":"Sci Trans Med"},{"key":"3667_CR92","doi-asserted-by":"publisher","first-page":"114639","DOI":"10.1016\/j.taap.2019.114639","volume":"379","author":"R Zeng","year":"2019","unstructured":"Zeng R et al (2019) Icariin protects rotenone-induced neurotoxicity through induction of SIRT3. Toxicol Appl Pharmcol 379:114639","journal-title":"Toxicol Appl Pharmcol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03667-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-022-03667-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03667-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T15:29:18Z","timestamp":1727537358000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-022-03667-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":92,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["3667"],"URL":"https:\/\/doi.org\/10.1007\/s11064-022-03667-0","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"19 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}